Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» generics
generics
Bristol Myers Squibb can grow through Revlimid generics, execs insist, pointing to key launches
Fierce Pharma
Thu, 02/4/21 - 08:15 pm
Bristol-Myers Squibb
generics
Revlimid
Zeposia
Reblozyl
Onureg
Teva, Mylan and fellow valsartan makers have to face consumer fraud claims: judge
Fierce Pharma
Mon, 02/1/21 - 11:07 pm
Teva Pharmaceutical
Mylan
Valsartan
generics
NDMA
Civica Rx lays out $124M sterile injectables plant, pegged to supply COVID-19 drugs and more
Fierce Pharma
Mon, 01/25/21 - 11:07 am
Civica Rx
drug manufacturing
generics
Phlow
Mark Cuban jumps out of the Shark Tank and into generic pharma with a plan to offer dirt-cheap drugs
Endpoints
Thu, 01/14/21 - 10:35 am
generics
Mark Cuban
Mark Cuban Cost Plus Drugs
US FDA approves Amphastar’s generic drug to treat severe hypoglycemia
Pharmaceutical Business Review
Tue, 12/29/20 - 10:58 am
FDA
Amphastar
hypoglycemia
generics
AvKARE bottles mix Viagra generics with antidepressant, triggering recall
Fierce Pharma
Mon, 12/14/20 - 10:54 am
generics
AvKARE
sildenafil
Viagra
antidepressants
trazodone
drug manufacturing
recalls
Amarin vs. the Generics: Who Will Win?
Motley Fool
Sun, 11/22/20 - 11:55 pm
Amarin
generics
Vascepa
patents
Major generic makers will partner with Medicines Patent Pool to pursue voluntary licenses for Covid-19 drugs
Stat
Wed, 11/11/20 - 11:46 pm
generics
patents
Date Is Set for Merger Between Mylan and Pfizer's Upjohn Unit
Motley Fool
Sun, 11/1/20 - 01:33 pm
M&A
FTC
Pfizer
Upjohn
Mylan
generics
FDA approves fewer generics in FY2020, ending record streak
RAPS.org
Thu, 10/22/20 - 11:06 am
FDA
generics
Teva back on the hook for $235M to GSK for heart drug infringement
Fierce Pharma
Mon, 10/5/20 - 11:42 pm
Teva
GSK
Patent Infringement
Coreg
generics
patents
CA Governor Looks to Disrupt State’s Generics Market to Promote Affordability
BioSpace
Wed, 09/30/20 - 10:39 am
California
generics
drug pricing
Generic drugmakers get guidance on tentative approvals, CRLs
RAPS.org
Mon, 09/28/20 - 10:29 pm
FDA
regulatory
generics
ANDAs
Californovation? California is Set to Become a Drug Manufacturer
FDA Law Blog
Wed, 09/16/20 - 10:47 am
California
generics
drug manufacturing
Ahead of merger with Pfizer's generic unit, Mylan makes $757M+ purchase for European thrombosis portfolio
Endpoints
Tue, 09/8/20 - 10:55 am
Mylan
Europe
generics
Aspen Pharmacare
M&A
thrombosis
Pfizer
FDA scolds Mylan for 'repeated' manufacturing problems
BioPharma Dive
Fri, 09/4/20 - 10:18 am
FDA
generics
Mylan
drug manufacturing
India
California may be the first state to develop its own generic drugs
LA Times, CA
Thu, 09/3/20 - 10:16 am
California
generics
Biocon and Mylan Launch Semglee; Biosimilar, Interchangeable Status Are Sought
Center for Biosimilars
Tue, 09/1/20 - 10:44 am
Biocon
Mylan
Semglee
generics
insulin
diabetes
biosimilars
FDA explains transfer of ownership policy for generics
RAPS.org
Sat, 08/29/20 - 11:49 pm
FDA
Orange Book
generics
Oncologists Were Paid To Prescribe Generic Chemotherapy (Here’s Why It Didn’t Change A Thing)
Forbes
Thu, 08/27/20 - 10:52 am
UnitedHealthcare
oncologists
generics
physicians
physician payments
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »